SEC Form 4 · accession 0001624453-15-000001
Xenon Pharmaceuticals Inc. · XENE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
MX Associates, LLP
10% Owner
Period of report
Dec 31, 2014
Accepted (ET)
Jan 7, 2015 · 12:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Dec 31, 2014 | J | 1,169,286 | $0.00 | D | 305,374 | D | |
| Common Shares | Dec 31, 2014 | J | 117,456 | $0.00 | D | 187,918 | D | |
| Common Shares | Dec 31, 2014 | J | 85,119 | $0.00 | D | 102,799 | D | |
| Common Shares | Dec 31, 2014 | J | 85,119 | $0.00 | D | 17,680 | D | |
| Common Shares | Dec 31, 2014 | J | 17,680 | $0.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transactions representing a distribution in kind of shares resulting from the dissolution of the Reporting Person.